Showing results (51-60 of 166) with videos related to

Sort By:
Pageof 17
Journal of Oncology|February 24, 2023
IDO1 Activity Predicts Lung Toxicity in Patients with Unresectable Stage III NSCLC and ChemoradiotherapyLinfang Wu, Yibo Gao, Daquan Wang, et al.
Mikrochimica Acta|March 16, 2024
Fabrication strategies for chiral self-assembly surfaceXiaohui Niu, Mei Yuan, Rui Zhao, et al.
Analytica Chimica Acta|April 8, 2020
Development of a high-coverage metabolome relative quantitative method for large-scale sample analysisZhi Zhou, Yanhua Chen, Yang Gao, et al.
International Journal of Radiation Oncology, Biology, Physics|December 29, 2021
Real-World Safety and Efficacy of Consolidation Durvalumab After Chemoradiation Therapy for Stage III Non-small Cell Lung Cancer: A Systematic Review and Meta-analysisYu Wang, Tao Zhang, Yilin Huang, et al.
Frontiers in Oncology|February 14, 2022
Progression-Free Survival and Time to Progression as Potential Surrogate Endpoints for Overall Survival in Chemoradiotherapy Trials in Limited-Stage Small-Cell Lung Cancer: A Systematic Review and Meta-AnalysisYin Yang, Jianyang Wang, Wenqing Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 5, 2010
Changes of circulating transforming growth factor-beta1 level during radiation therapy are correlated with the prognosis of locally advanced non-small cell lung cancerLujun Zhao, Wei Ji, Li Zhang, et al.
Radiation Oncology (London, England)|December 4, 2017
Health-related quality of life in long-term survivors of unresectable locally advanced non-small cell lung cancerJuntao Ran, Jingbo Wang, Nan Bi, et al.
Thoracic Cancer|April 5, 2016
Radical thoracic radiotherapy may provide favorable outcomes for stage IV non-small cell lung cancerJingbo Wang, Zhe Ji, Xiaozhen Wang, et al.
Cancer Management and Research|October 29, 2020
Sparing Organs at Risk with Simultaneous Integrated Boost Volumetric Modulated Arc Therapy for Locally Advanced Non-Small Cell Lung Cancer: An Automatic Treatment Planning StudyDaquan Wang, Jiayun Chen, Xiaodong Zhang, et al.
Frontiers in Oncology|September 12, 2022
Corrigendum: Progression-free survival and time to progression as potential surrogate endpoints for overall survival in chemoradiotherapy trials in limited-stage small-cell lung cancer: A systematic review and meta-analysisYin Yang, Jianyang Wang, Wenqing Wang, et al.
Pageof 17